Zimbabwe has turned down a major American health deal worth 367 million US dollars (£272m) over five years because of the United States' request for sensitive information.
This rejection came to light after a official document from December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "skewed".
An official representative later stated that the United States was seeking biological samples for scientific study and commercial gain while was unwilling to guarantee the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had donated over $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further talks to reach a deal acceptable to all parties so the country's vital HIV treatment initiative can continue.
Wider Implications
This rejection follows a comparable situation in neighbouring Kenya, where a high court suspended a related deal with the US following concerns were filed about the safety of citizens' health data.
After resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing direct bilateral deals to enhance openness and accountability.
As per statements, 16 African countries have so far agreed to these new agreements, constituting over $18.3bn in committed funds.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy through US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Our nation was requested to share its genetic material and health information over an extended period, without any corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"Put simply, our country would provide the basic resources for scientific discovery with no assurance that the end products would be available to our population if a future disease outbreak emerge."
National Interest and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending frameworks already set up via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system created to manage potential global health emergencies.
"This framework is designed to guarantee that when a nation provides its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
These objections over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how subsequent collaboration might be structured in a manner that respects the independence and interests of each country."
Health Experts Reaction
A leading public health body stated it understood the official position, but suggested that negotiations should continue considering a large portion of the country's Aids initiatives relied on international support.
"In cases where specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group commented.
This impasse highlights the complex debate between accepting crucial international aid and protecting local interests in an ever more interconnected world.